Iron Deficiency Anemia Treatment Market Growth Expected To Reach $16.17 Billion By 2030 At 12.8% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Forecasted Market Size Trajectory Of The Iron Deficiency Anemia Treatment Market From 2026 To 2030?
The iron deficiency anemia treatment market has experienced rapid growth in recent years. This market is projected to expand from $8.83 billion in 2025 to $9.98 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.0%. Historically, this growth has been driven by several factors, including the increasing prevalence of iron deficiency disorders, enhanced diagnosis of anemia in chronic diseases, the broadening of hospital-based treatment protocols, the accessibility of oral iron supplements, and an increasing awareness regarding anemia management.
The iron deficiency anemia treatment market is projected to experience significant expansion in the coming years. It is anticipated to reach a value of $16.17 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.8%. This growth during the forecast period can be attributed to factors such as the increasing susceptibility of the geriatric population, a rising demand for rapid iron repletion therapies, the expansion of injectable iron usage, a growing focus on patient-centric treatment models, and advancements in iron formulation technologies. Furthermore, key trends expected in this period include an increasing adoption of intravenous iron therapies, a rising use of high-bioavailability iron formulations, a growing emphasis on personalized anemia treatment approaches, the expansion of outpatient and home-based iron therapy, and improved patient monitoring and compliance tools.
Access Your Free Sample Report For In-Depth Market Analysis:
What Key Drivers Are Fueling The Growth Of The Iron Deficiency Anemia Treatment Market?
The projected rise in chronic kidney disease (CKD) is anticipated to propel the expansion of the iron deficiency anemia treatment market in the coming years. Chronic kidney disease (CKD) is characterized by a gradual decline in kidney function over time. The increase in CKD cases can be linked to growing rates of diabetes, as persistently high blood sugar levels harm the kidney’s blood vessels, hindering their ability to filter waste. Treatment for iron deficiency anemia assists individuals with chronic kidney disease by improving oxygen delivery to tissues, lessening fatigue, and enhancing quality of life, and it may also improve kidney function by addressing the anemia that frequently stems from reduced erythropoietin production in CKD. For instance, in April 2024, a report published by AstraZeneca, a UK-based pharmaceutical company, projected that by 2032, up to 16.5% of the population across eight countries, including the United States, Brazil, the United Kingdom, Spain, Germany, the Netherlands, China, and Australia, will be affected by chronic kidney disease (CKD), with advanced-stage cases seeing a significant increase of up to 59.3%. Consequently, the growing incidence of chronic kidney disease is fueling growth in the iron deficiency anemia treatment market.
What Are The Key Segment Divisions In The Iron Deficiency Anemia Treatment Market Segment Structure?
The iron deficiency anemia treatment market covered in this report is segmented –
1) By Treatment Type: Medications, Blood Transfusions, Other Treatment Types
2) By Drug Type: Ferrous Sulfate, Iron Carbohydrates, Other Drug Types
3) By Therapy Areas: Inflammatory Bowel Disease, Oncology, Other Therapy Areas
4) By Route Of Administration: Oral, Injectable
5) By End User: Hospitals, Clinics, Home Care Settings, Pharmacies
Subsegments:
1) By Medications: Oral Iron Supplements, Intravenous Iron Therapy, Iron-Based Injections, Erythropoiesis-Stimulating Agents
2) By Blood Transfusions: Packed Red Blood Cells Transfusion, Whole Blood Transfusion
3) By Other Treatment Types: Dietary Modifications, Iron Infusion Therapy, Long-Term Maintenance Iron Therapy
What Trends Are Influencing The Iron Deficiency Anemia Treatment Market?
Major companies operating in the iron deficiency anemia treatment market are concentrating on developing next-generation solutions, such as iron injections, to enhance treatment efficacy, safety, and patient convenience. An iron injection refers to a new or significantly improved injectable iron therapy that represents a major advancement in the treatment of iron deficiency or iron deficiency anemia. For instance, in March 2024, Cadila Pharmaceuticals, an India-based pharmaceutical company, launched Redshot FCM, an intravenous iron therapy using ferric carboxymaltose to treat iron deficiency anemia (IDA). It offers unique features, including an advanced ferric carboxymaltose formulation for rapid iron replenishment, minimal anaphylaxis risk, high-dose single-infusion administration for swift correction, and pediatric applicability (1+ years) alongside adult use. It accelerates hemoglobin recovery and targets high-risk groups, including pregnant women and cancer patients, with superior tolerability.
Which Organizations Are Engaged In The Iron Deficiency Anemia Treatment Market?
Major companies operating in the iron deficiency anemia treatment market are Sanofi SA, Fresenius SE & Co. KGaA, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Daiichi Sankyo Company Limited, Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd., Pharmascience Inc., American Regent Inc., PharmaNutra S.p.A., Rockwell Medical Inc., Keryx Biopharmaceuticals Inc., Pharmacosmos A/S, AdvaCare Pharma USA LLC, Apotex Inc., Shield Therapeutics plc, CSL Vifor AG, Abbott Laboratories, Bayer AG, Pfizer Inc., Cipla Limited, Dr. Reddy’s Laboratories Ltd.
Get The Full Iron Deficiency Anemia Treatment Market Report:
Where Is The Iron Deficiency Anemia Treatment Market Most Concentrated Geographically?
North America was the largest region in the iron deficiency anemia treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iron deficiency anemia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Iron Deficiency Anemia Treatment Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Iron Deficiency Anemia Treatment Market 2026, By The Business Research Company
Hemochromatosis Iron Overload Disease Treatment Market Report 2026
Anemia And Other Blood Disorder Drugs Market Report 2026
Chemotherapy Induced Anemia Market Report 2026
https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-anemia-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
